SCHEMBL28043724

SCHEMBL28043724

CNc1cc(OC(=O)c2ccccc2)nc(N)n1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 9/20 0.61
MAPT P10636 4/20 0.45
KMT2A Q03164 4/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TSHR P16473 1/20 0.42
MEN1 O00255 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SLC6A3 Q01959 1/20 0.40
ROCK1 Q13464 1/20 0.40
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15305671 0.77 MEN1 (0.54) NUDT1MAPTKMT2AMEN1CCNA2
SCHEMBL15305670 0.73 NPC1 (0.56) MAPTKMT2ASMN1; SMN2MEN1ALDH1A1
SCHEMBL6277127 0.72 MAPT (0.47) MAPTKMT2AHPGDKDM4ESMN1; SMN2
SCHEMBL16852189 0.72 KMT2A (0.47) MAPTKMT2AKDM4ESMN1; SMN2TSHR
SCHEMBL16463778 0.71 NUDT1 (0.60) NUDT1ALDH1A1HTR6
SCHEMBL15757956 0.70 NUDT1 (0.50) NUDT1ROCK1
SCHEMBL27302783 0.70 KMT2A (0.50) MAPTKMT2AHPGDKDM4ESMN1; SMN2
SCHEMBL27552383 0.70 PARP10 (0.42) MAPTKMT2AHPGDKDM4ESMN1; SMN2
SCHEMBL22557464 0.70 ASIC3 (0.46) MAPTKMT2AHPGDKDM4ESMN1; SMN2
SCHEMBL16852232 0.69 TSHR (0.46) MAPTKMT2AHPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 CN disclosed